Trial
NCT04930991
High Dose Omeprazole in Patients With Pancreatic Cancer
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Oklahoma
Collaborators
—
Condition
Exocrine Pancreatic Cancer
Intervention
Omeprazole
Why stopped
Translational scientist left university
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-01